发明名称 |
LIVER SELECTIVE THERAPY |
摘要 |
A method of pharmaceutical therapy comprising administering a pharmaceutical complementary medicine or herbal product orally at a dose sufficient to provide a clinically effective level in the portal vein and less than that required to provide a clinically effective blood level in the peripheral circulation to thereby provide a dose-delivery rate having a selective clinical effect in the liver.
|
申请公布号 |
CA2389616(A1) |
申请公布日期 |
2001.05.10 |
申请号 |
CA20002389616 |
申请日期 |
2000.11.01 |
申请人 |
HOWARD J. SMITH ASSOCIATES PTY LTD. |
发明人 |
SMITH, HOWARD J. |
分类号 |
A61K9/16;A61K9/22;A61K31/138;A61K31/19;A61K31/22;A61K31/351;A61K31/366;A61K31/40;A61K31/56;A61K31/573;A61P1/16;A61P3/06;A61P9/12;A61P31/12;(IPC1-7):A61K31/13;A61K31/365;A61K31/57 |
主分类号 |
A61K9/16 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|